Transcat director sells 7,312 shares at $85.6
A TRANSCAT INC director sold 7,312 TRNS shares and now holds 4,346 shares plus 1,587 time-vesting RSUs.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TRANSCAT INC (TRNS) director Oksana S. Dominach reported selling 7,312 shares of common stock on September 2, 2026 at an average price of $85.5958 per share in an open-market or private transaction. After this sale, she held 4,346 common shares directly and 1,587 Restricted Stock Units (RSUs) that convert into common stock on a one-for-one basis and, except as otherwise provided in the award agreement, vest on September 10, 2026. No Rule 10b5-1 trading plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, $.50 par value | 7,312 | $85.5958 | $626K |
| holding | Restricted Stock Units F1, F2 | -- | -- | -- |
Footnotes (2)
- F1. These restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- F2. These RSUs were granted in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award agreement, vest on September 10, 2026.
Key Figures
Key Terms
Restricted Stock Units financial
Rule 16b-3 regulatory
one-for-one basis financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TRANSCAT INC (TRNS) report for Oksana S. Dominach?
What Restricted Stock Units (RSUs) position does the TRNS director report?
Was the TRNS insider transaction made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.